Pfizer will begin shipping its biosimilar version of J&J’s rheumatoid arthritis drug Remicade in late November 2016 at a 15% discount to current wholesale prices.

Teva Pharmaceutical Industries hopes to win U.S. approval by late 2017 or early 2018 for its version of Mylan’s EpiPen device to treat severe allergic reactions.

IMS analysis revealed that lower-cost copies of complex biotechnology drugs could save the United States and Europe’s five top markets as much as €98 billion ($110 billion) by 2020.

Immunocore was recognized as SCRIP Awards 2015’s Biotech of the Year. Immunocore is a world-leading biotech company developing novel T cell receptor (TCR) based biological drugs for the treatment of cancer, viral infections and autoimmune disease.

To reach payer audiences, companies have to focus far less on promotional tactics and show the value of their products.

Frank X. Powers and Lorna Weir have teamed up to form a new venture – Elevate Healthcare Marketing. The reason why, these executives explain in their launch press release, is “Because they believe that truly helping clients raise the value of their offerings in the dynamic world of healthcare now demands a different type of collaboration.”

Indianapolis-based Eli Lilly and Company is on a roll, announcing that between 2014 and 2023, it may launch 20 new products.

Startup Homology Medicines Launches With $43 Million Series A, To Be Led By Three Former Shire Execs   May 2, 2016By Mark Terry, BioSpace.com Breaking News Staff   Lexington, Mass.-based Homology Medicines launched today with a $43.5 million Series A preferred stock financing. The round was co-led by 5AM Ventures and ARCH Venture Partners. They […]

February 19, 2016By Mark Terry, BioSpace.com Breaking News Staff   Cambridge, Mass.-based venture capital firm Atlas Venture launched another Cambridge biotech startup yesterday, AvroBio. No financial details were disclosed. The company is founded on two novel cell and gene therapies that came out of the laboratories of Christopher Paige and Jeffrey Medin at the University […]

CAMBRIDGE, Mass. – Celebrating its one-year anniversary since launching Unum Therapeutics, a company developing cellular immunotherapies for cancer treatment, took up new office space in one of the hottest real estate areas for pharma and biotech companies. The company opened a new 33,000 square-foot headquarters in Cambridge, Mass. and is expecting the new space will […]